JUBLIA (Valeant Pharmaceuticals North America LLC)
Welcome to the PulseAid listing for the JUBLIA drug offered from Valeant Pharmaceuticals North America LLC. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America LLC |
NON-PROPRIETARY NAME: | efinaconazole |
SUBSTANCE NAME: | EFINACONAZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |
ROUTE: | TOPICAL |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-06-06 |
END MARKETING DATE: | 0000-00-00 |
JUBLIA HUMAN PRESCRIPTION DRUG Details:
Item Description | JUBLIA from Valeant Pharmaceuticals North America LLC |
LABELER NAME: | Valeant Pharmaceuticals North America LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/mL) |
START MARKETING DATE: | 2014-06-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0187-5400_424ea0a1-aaad-43b3-b0be-f78c27e8858c |
PRODUCT NDC: | 0187-5400 |
APPLICATION NUMBER: | NDA203567 |
Other EFINACONAZOLE Pharmaceutical Manufacturers / Labelers: